Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now early-phase tilt small index

Memory Loss: early-phase trial registry

6 of 13 indexed Memory Loss trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,315 of 28,707 conditions by registered trial count.

13 US clinical trials · 6 currently recruiting · #1,315 of 28,707 conditions by registered trial count

Memory Loss: 13 US clinical trials tracked, 6 recruiting.

Memory Loss is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is John Wesson Ashford Jr, running 1 of these trials.

Enrollment posture brief

Registry condition memory-loss

OPEN 6 | RECR 46% | LATE 0 | EARLY 2 | RANK #1315 | SPON 1

Nearest open-share peer: B-cell Lymphoma (46% recruiting · 39 trials)

ACL Injury61.5%Acute Biphenotypic Leukemia46.2%Memory Loss (this)46%Accidental Falls30.8%Actinic Keratoses23.1%
Open-enrollment share among volume-matched conditions near Memory Loss

Memory Loss lists 6 open slots (46% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Memory Loss on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Memory Loss recruits in line with its size-band peers.

    6 of 13 indexed trials (46.2%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Memory Loss trials is spread across many organizations.

    John Wesson Ashford Jr accounts for 1 of 13 trials (7.7%). 13 distinct sponsors appear on at least one study for this condition label.

  3. Typical Memory Loss enrolment sits around 150 participants.

    Median target enrolment is 150 among the 13 trials that report a genuine target (sentinel values excluded). 5 of those (38.5%) plan for fewer than 100 participants.

  4. Memory Loss research is mostly interventional.

    10 interventional and 3 observational studies make up this index (76.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21

Open and recent trials

13 total, page 1 of 1

RECRUITING 1,200 participants

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

GAP Innovations, PBC

NCT06584357

RECRUITING NA 216 participants

A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses

Arizona State University

NCT05877196

RECRUITING NA 150 participants

Brain Health Virtual Reality Study

University of California, San Diego

NCT06124339

RECRUITING NA 144 participants

Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia

Hebrew SeniorLife

NCT05661084

RECRUITING NA 80 participants

Targeted Transcranial Magnetic Stimulation to Improve Hippocampal-dependent Declarative Memory Abilities

University of Nebraska

NCT03574207

RECRUITING Early Phase 1 60 participants

Pharmacological Modulation of Brain Oscillations in Memory Processing

University of Texas Southwestern Medical Center

NCT05594017

ACTIVE NOT RECRUITING 2,000 participants

Screening for Memory Studies

John Wesson Ashford Jr

NCT01123018

ACTIVE NOT RECRUITING NA 342 participants

The PorchLight Project

University of Minnesota

NCT05550727

ACTIVE NOT RECRUITING 340 participants

Couples Health Aging, Rhythms and Sleep Study

University of Utah

NCT05952284

ACTIVE NOT RECRUITING NA 84 participants

Remote Game-based Exercise Program for Cognitive and Motor Function Improvement

University of California, Los Angeles

NCT05235113

COMPLETED NA 154 participants

Efficacy of Early Stage Alzheimer's Support Groups

University of Washington

NCT00391794

COMPLETED Phase 2 96 participants

Phytoestrogens and Memory Decline in Menopause

National Center for Complementary and Integrative Health (NCCIH)

NCT00051402

COMPLETED NA 69 participants

Noninvasive Brain Stimulation for Mild Cognitive Impairment

Palo Alto Veterans Institute for Research

NCT03331796

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Named interventions

Most-linked intervention names on Memory Loss records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Educational Seminar Behavioral
1 trials
Early Stage Memory Loss Support Group Behavioral
1 trials
Placebo rTMS (Inactive) Device
1 trials
Active rTMS (Bilateral LPC) Device
1 trials
Active rTMS (Bilateral DLPFC) Device
1 trials
Isoflavones Drug
1 trials
Memtrax Memory screening test Behavioral
1 trials
No Tele-Exergame Platform Device
1 trials

US sites by state

Facility locations filed on Memory Loss trials. A trial with sites in several states counts in each.

California 4 trials
Texas 2 trials
Ohio 2 trials
Washington 1 trials
Utah 1 trials
Rhode Island 1 trials
Pennsylvania 1 trials
New York 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Memory Loss page

13 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Memory Loss condition card totals 13 registered trials; most-linked intervention Educational Seminar; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.